4DX — 4DMedical Income Statement
0.000.00%
Last trade - 00:00- AU$115.73m
- AU$104.60m
- AU$3.75m
Annual income statement for 4DMedical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.23 | 0.217 | 1.05 | 0.719 | 3.75 |
| Cost of Revenue | |||||
| Gross Profit | 0.111 | 0.125 | 0.281 | 0.684 | 3.52 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.2 | 19 | 25.5 | 32.2 | 40.7 |
| Operating Profit | -14 | -18.7 | -24.5 | -31.5 | -36.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -22 | -21.4 | -24.5 | -31.1 | -35.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22 | -21.4 | -24.6 | -31.5 | -36 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -22 | -21.4 | -24.6 | -31.5 | -36 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -22 | -21.4 | -24.6 | -31.5 | -36 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.083 | -0.082 | -0.084 | -0.105 | -0.093 |